LIGAND PHARMACEUTICALS INCORPORATED Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $602.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $602.00K, a 51.49% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $1.24M, a 2.97% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $1.28M.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was -$12.08M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $602.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $1.24M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $1.28M 10-K · filed 2025-02-28 | |
| 2021-12-31 | -$12.08M 10-K · filed 2024-02-29 | -$11.92M 10-K · filed 2022-02-28 |
| 2020-12-31 | -$623.00K 10-K · filed 2023-02-28 | -$362.00K 10-K · filed 2021-02-24 |
| 2019-12-31 | -$819.00K 10-K · filed 2022-02-28 | |
| 2018-12-31 | -$8.13M 10-K · filed 2021-02-24 | |
| 2017-12-31 | -$4.02M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $263.00K 10-K · filed 2019-02-28 | |
| 2015-12-31 | $140.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $89.00K 10-K · filed 2017-02-28 | -$556.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | -$556.00K 10-K · filed 2016-11-14 | |
| 2012-12-31 | -$581.00K 10-K · filed 2015-02-23 | $312.00K 10-K · filed 2013-03-14 |
| 2011-12-31 | $597.00K 10-K/A · filed 2014-12-12 | |
| 2010-12-31 | $510.00K 10-K · filed 2013-03-14 |